Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D05LQX
|
||||
Former ID |
DIB015458
|
||||
Drug Name |
BOL-303259-X
|
||||
Synonyms |
Latanoprostene bunod; Latanoprostene bunod); NCX-116; PF-03187207; PF-3187207; BOL-303259-X1; NO donors (glaucoma), NicOx/Pfizer; NO-donating prostaglandin F2-alpha analogs (glaucoma), Pfizer; NO-donating prostaglandin F2-alpha analogs (glaucoma), NicOx/Pfizer; Nitric oxide-donating prostaglandin F2-alpha analogs (eye disease), NicOx/Pfizer; NO-donating prostaglandin F2-alpha analogs (glaucoma), NicOx/ Bausch & Lomb
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Renal cancer [ICD9: 140-229, 189; ICD10:C64] | Phase 3 | [524354] | ||
Company |
NicOx SA; bausch & lomb
|
||||
Structure |
Download2D MOL |
||||
Formula |
C27H41NO8
|
||||
Canonical SMILES |
O[C@H](CC[C@H]1[C@H](O)C[C@H](O)[C@@H]1C\\C=C/CCCC(=O)O<br />CCCCON(=O)=O)CCc2ccccc2
|
||||
InChI |
1S/C27H41NO8/c29-22(15-14-21-10-4-3-5-11-21)16-17-24-23(25(30)20-26(24)31)12-6-1-2-7-13-27(32)35-18-8-9-19-36-28(33)34/h1,3-6,10-11,22-26,29-31H,2,7-9,12-20H2/b6-1-/t22-,23+,24+,25-,26+/m0/s1
|
||||
InChIKey |
LOVMMUBRQUFEAH-UIEAZXIASA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Prostaglandin F2-alpha receptor | Target Info | Agonist | [531388] | |
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.